Brief: Sprint Bioscience Starts Final Negotiations Regarding STK25-Project
Nov 15 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* STARTS FINAL NEGOTIATIONS REGARDING STK25-PROJECT
* ENTERED INTO MUTUAL AGREEMENT ON TERM SHEET FOR STK25
PROJECT
* ENTERS INTO AGREEMENT WITH PHARMACEUTICAL CO WITH FOCUS ON
DIABETES AND METABOLIC DISEASES
Source text for Eikon: ID:nWkr4sgrNs
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program